BMCC1, Which is an Interacting Partner of BCL2, Attenuates AKT Activity, Accompanied by Apoptosis

Overview

Journal Cell Death Dis

Specialties Cell Biology
General Medicine

Date 2015 Jan 23

PMID 25611382

Citations 10

Authors

Y Tatsumi

R Takano

M S Islam

T Yokochi

M Itami

Y Nakamura

A Nakagawara

Affiliations

Soon will be listed here.

Abstract

BNIP2 and Cdc42GAP homology (BCH) motif-containing molecule at the carboxyl-terminal region 1 (BMCC1) gene is highly expressed in patients with favorable neuroblastoma (NB). It encodes a 340-kDa protein with a conserved BCH scaffold domain that may regulate signaling networks and multiple cellular functions, including apoptosis. In this study, we determined the mechanism by which BMCC1 promotes apoptosis in human NB and non-NB cells, as BMCC1 is normally expressed in various organs, particularly in neuronal and epithelial tissues. We demonstrated in this report that BMCC1 was induced by DNA damage, one of the triggers of intrinsic apoptosis. Accordingly, we investigated whether BMCC1 expression impacts intracellular signals in the regulation of apoptosis via its C-terminal region containing BCH scaffold domain. BMCC1 decreased phosphorylation of survival signals on AKT and its upstream kinase PDK1. BMCC1 upregulation was correlated with the activation of forkhead box-O3a (FOXO3a) (a downstream inducer of apoptosis, which is suppressed by AKT) and induction of BCL2 inhibitor BIM, suggesting that BMCC1 negatively regulates phosphorylation pathway of AKT, resulted in apoptosis. In addition, we found that BNIP2 homology region of BMCC1 interacts with BCL2. Intrinsic apoptosis induced by DNA damage was enhanced by BMCC1 overexpression, and was diminished by knockdown of BMCC1. Taken together, we conclude that BMCC1 promotes apoptosis at multiple steps in AKT-mediated survival signal pathway. These steps include physical interaction with BCL2 and attenuation of AKT-dependent inhibition of FOXO3a functions, such as transcriptional induction of BIM and phosphorylation of ataxia telangiectasia-mutated (ATM) after DNA damage. We propose that downregulation of BMCC1 expression, which is frequently observed in unfavorable NB and epithelial-derived cancers, may facilitate tumor development by abrogating DNA damage repair and apoptosis.

Citing Articles

Differences between human male and female neutrophils in mRNA, translation efficiency, protein, and phosphoprotein profiles.

Pilling D, Consalvo K, Kirolos S, Gomer R Res Sq. 2024; .

PMID: 38746380 PMC: 11092807. DOI: 10.21203/rs.3.rs-4284171/v1.

ERK Inhibitor Ulixertinib Inhibits High-Risk Neuroblastoma Growth In Vitro and In Vivo.

Yu Y, Zhao Y, Choi J, Shi Z, Guo L, Elizarraras J Cancers (Basel). 2022; 14(22).

PMID: 36428626 PMC: 9688897. DOI: 10.3390/cancers14225534.

Prune homolog 2 with BCH domain (PRUNE2) gene expression is associated with feed efficiency-related traits in Nelore steers.

Lima A, Malheiros J, Afonso J, Petrini J, Coutinho L, Diniz W Mamm Genome. 2022; 33(4):629-641.

PMID: 35840822 DOI: 10.1007/s00335-022-09960-1.

PRUNE2 inhibits progression of colorectal cancer and .

Li T, Huang S, Yan W, Zhang Y, Guo Q Exp Ther Med. 2022; 23(2):169.

PMID: 35069850 PMC: 8764654. DOI: 10.3892/etm.2021.11092.

The glucose-sensing transcription factor MLX balances metabolism and stress to suppress apoptosis and maintain spermatogenesis.

Carroll P, Freie B, Cheng P, Kasinathan S, Gu H, Hedrich T PLoS Biol. 2021; 19(10):e3001085.

PMID: 34669700 PMC: 8528285. DOI: 10.1371/journal.pbio.3001085.

References

Gilley J, Coffer P, Ham J . FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J Cell Biol. 2003; 162(4):613-22. PMC: 2173804. DOI: 10.1083/jcb.200303026. View

Harris J, Richards R, Chow C, Lee S, Kim M, Buck M . BMCC1 is an AP-2 associated endosomal protein in prostate cancer cells. PLoS One. 2013; 8(9):e73880. PMC: 3765211. DOI: 10.1371/journal.pone.0073880. View

Tatsumi Y, Ohta S, Kimura H, Tsurimoto T, Obuse C . The ORC1 cycle in human cells: I. cell cycle-regulated oscillation of human ORC1. J Biol Chem. 2003; 278(42):41528-34. DOI: 10.1074/jbc.M307534200. View

Evans A, GERSON J, SCHNAUFER L . Spontaneous regression of neuroblastoma. Natl Cancer Inst Monogr. 1976; 44:49-54. View

Vaux D, Cory S, Adams J . Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 1988; 335(6189):440-2. DOI: 10.1038/335440a0. View

Nakagawara A, Arima M, Azar C, Scavarda N, Brodeur G . Inverse relationship between trk expression and N-myc amplification in human neuroblastomas. Cancer Res. 1992; 52(5):1364-8. View

Nakagawara A, Scavarda N, Azar C, Cantor A, Brodeur G . Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med. 1993; 328(12):847-54. DOI: 10.1056/NEJM199303253281205. View

Kogner P, Barbany G, Dominici C, Castello M, Raschella G, Persson H . Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res. 1993; 53(9):2044-50. View

Boyd J, Malstrom S, Subramanian T, Venkatesh L, Schaeper U, Elangovan B . Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell. 1994; 79(2):341-51. DOI: 10.1016/0092-8674(94)90202-x. View

10.

Datta S, Dudek H, Tao X, Masters S, Fu H, Gotoh Y . Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 1997; 91(2):231-41. DOI: 10.1016/s0092-8674(00)80405-5. View

11.

OConnor L, Strasser A, OReilly L, Hausmann G, Adams J, Cory S . Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J. 1998; 17(2):384-95. PMC: 1170389. DOI: 10.1093/emboj/17.2.384. View

12.

Nakagawara A, Brodeur G . Role of neurotrophins and their receptors in human neuroblastomas: a primary culture study. Eur J Cancer. 1998; 33(12):2050-3. DOI: 10.1016/s0959-8049(97)00280-3. View

13.

Ren X, Schwartz M . Regulation of inositol lipid kinases by Rho and Rac. Curr Opin Genet Dev. 1998; 8(1):63-7. DOI: 10.1016/s0959-437x(98)80063-4. View

14.

Vlietstra R, van Alewijk D, Hermans K, van Steenbrugge G, Trapman J . Frequent inactivation of PTEN in prostate cancer cell lines and xenografts. Cancer Res. 1998; 58(13):2720-3. View

15.

Brunet A, Bonni A, Zigmond M, Lin M, Juo P, Hu L . Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 1999; 96(6):857-68. DOI: 10.1016/s0092-8674(00)80595-4. View

16.

Puthalakath H, Huang D, OReilly L, King S, Strasser A . The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell. 1999; 3(3):287-96. DOI: 10.1016/s1097-2765(00)80456-6. View

17.

Matthay K, Villablanca J, Seeger R, Stram D, Harris R, Ramsay N . Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med. 1999; 341(16):1165-73. DOI: 10.1056/NEJM199910143411601. View

18.

Maris J . The biologic basis for neuroblastoma heterogeneity and risk stratification. Curr Opin Pediatr. 2005; 17(1):7-13. DOI: 10.1097/01.mop.0000150631.60571.89. View

19.

Biswas S, Liu D, Greene L . Bim is a direct target of a neuronal E2F-dependent apoptotic pathway. J Neurosci. 2005; 25(37):8349-58. PMC: 6725681. DOI: 10.1523/JNEUROSCI.1570-05.2005. View

20.

Altomare D, Testa J . Perturbations of the AKT signaling pathway in human cancer. Oncogene. 2005; 24(50):7455-64. DOI: 10.1038/sj.onc.1209085. View